BLOOD BILIRUBIN UNCONJUGATED DECREASED

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting BLOOD BILIRUBIN UNCONJUGATED DECREASED:

# Drug Count
0 ALEMTUZUMAB 3
1 DIMETHYL FUMARATE 2
2 ADALIMUMAB 1
3 ATORVASTATIN CALCIUM 1
4 BACLOFEN 1
5 DALFAMPRIDINE 1
6 DIAZEPAM 1
7 EVEROLIMUS 1
8 EXEMESTANE 1
9 FERROUS SULFATE 1
See all common drugs associated with BLOOD BILIRUBIN UNCONJUGATED DECREASED

BLOOD BILIRUBIN UNCONJUGATED DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ONASEMNOGENE ABEPARVOVEC-XIOI 1 0.0007
1 ALEMTUZUMAB 3 0.0002
2 PREDNISOLONE ACETATE 1 0.0001
3 ISONIAZID 1 0.0001
4 RIBOCICLIB 1 0.0001
5 EXEMESTANE 1 0.0001
6 FULVESTRANT 1 0.0000
7 LETROZOLE TABLETS 1 0.0000
8 FERROUS SULFATE 1 0.0000
9 LETROZOLE 1 0.0000
See all drugs enriched for association with BLOOD BILIRUBIN UNCONJUGATED DECREASED

BLOOD BILIRUBIN UNCONJUGATED DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 3 0.0002
1 Antimycobacterial [EPC] 1 0.0001
2 Estrogen Receptor Antagonist [EPC] 1 0.0000
3 Aromatase Inhibitor [EPC] 2 0.0000
4 Potassium Channel Blocker [EPC] 1 0.0000
5 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin C [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with BLOOD BILIRUBIN UNCONJUGATED DECREASED